2279 — Yonghe Medical Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual cashflow statement for Yonghe Medical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	71.5	231	210	-109	-585
Depreciation
Amortisation
Non-Cash Items	27.3	47.1	47	-51.9	132
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-46	64.4	-20.9	-172	102
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	182	502	437	-109	-17.2
Capital Expenditures	-108	-143	-191	-244	-171
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	2.76	0.459	-3.3	-407	417
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-105	-142	-194	-651	246
Financing Cash Flow Items	-1.27	-4.87	1,092	-33.9	-2.34
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-55.8	-156	1,028	-333	-185
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	21.3	203	1,273	-1,001	38.1